Effects of Incentive Spirometry With and Without Aerobic Exercises in Interstitial Lung Disease

NCT ID: NCT06133998

Last Updated: 2023-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-20

Study Completion Date

2023-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Effects of Incentive spirometry with and without Aerobic exercises on dyspnea, exercise capacity and quality of life in interstitial lung disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Interstitial lung disease is the large group of diseases most of which cause progressive scarring of lung tissue. The scarring associated with interstitial lung disease eventually affects participants ability to breathe and get enough oxygen into participants bloodstream. This is occurring by the long term work in dusty places or factories Randomized control trials will be conducted in DHQ hospital Layyah through the convent sampling techniques on patients which will be allocated through convenience sampling technique on 32 patients which will be allocated through simple random sampling through sealed opaque enveloped into group A and group B. After the conventional treatment Group A will be treated with aerobic exercise and Group B will be treated without the aerobic exercise. In group A check the effect of spirometry with aerobic exercise (walking, jogging, running and cycling) and group B check the effect of spirometry without the aerobic exercise and dyspnea by using the 6 mint walk test, Borage scale, PFT, chest expansions and quality of life questionnaire. investigators apply the aerobic exercise by using the spirometer on the interstitial lung diseases patient and check the effectiveness of dyspnea, exercise capacity and quality of life of the patient. Data will be collect by the questioner and Data will be analyzed using SPSS software version 21. After assessing normality of data by Shapiro - wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Interstitial Lung Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

incentive spirometry with aerobic exercises

Group A: Aerobic exercise (running, jugging, cycling, walking) will be given to the group A for the checking the effect of incentive spirometer

* In sitting position, for the relaxation of body, patient will take a deep breath.
* In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung.
* This schedule will be following supervised exercise training for a minimum 60 minutes 3 days a week in moderate patient,75 minutes in moderate to vigorous patients and 150 minutes in healthy patients
* We will check the dyspnea of the patient by the borage scale
* We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test
* We will check the quality of life by the questionnaire.

Group Type EXPERIMENTAL

incentive spirometer with aerobic exercises

Intervention Type DEVICE

Group A: Aerobic exercise (running, jugging, cycling, walking) will be given to the group A for the checking the effect of incentive spirometer

* In sitting position, for the relaxation of body, patient will take a deep breath.
* In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. This schedule will be following supervised exercise training for a minimum 60 minutes 3 days a week in moderate patient,75 minutes in moderate to vigorous patients and 150 minutes in healthy patients
* We will check the dyspnea of the patient by the borage scale
* We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test
* We will check the quality of life by the questionnaire.

incentive spirometry without aerobic exercises

Group B: In group B we will check the effects of incentive spirometer without the aerobic exercise.

* In aerobic exercise following treatment protocol will be involve
* In sitting position, for the relaxation of body, patient will take a deep breath.
* In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung.
* We will check the dyspnea of the patient by the borage scale
* We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test
* We will check the quality of life by the questionnaire.
* We will check the chest expansion by measuring tap.

Group Type ACTIVE_COMPARATOR

incentive spirometry without aerobic exercises

Intervention Type DEVICE

Group B: In group B we will check the effects of incentive spirometer without the aerobic exercise.

* In aerobic exercise following treatment protocol will be involve
* In sitting position, for the relaxation of body, patient will take a deep breath.
* In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung.
* We will check the dyspnea of the patient by the borage scale
* We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test
* We will check the quality of life by the questionnaire.
* We will check the chest expansion by measuring tap.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

incentive spirometer with aerobic exercises

Group A: Aerobic exercise (running, jugging, cycling, walking) will be given to the group A for the checking the effect of incentive spirometer

* In sitting position, for the relaxation of body, patient will take a deep breath.
* In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. This schedule will be following supervised exercise training for a minimum 60 minutes 3 days a week in moderate patient,75 minutes in moderate to vigorous patients and 150 minutes in healthy patients
* We will check the dyspnea of the patient by the borage scale
* We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test
* We will check the quality of life by the questionnaire.

Intervention Type DEVICE

incentive spirometry without aerobic exercises

Group B: In group B we will check the effects of incentive spirometer without the aerobic exercise.

* In aerobic exercise following treatment protocol will be involve
* In sitting position, for the relaxation of body, patient will take a deep breath.
* In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung.
* We will check the dyspnea of the patient by the borage scale
* We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test
* We will check the quality of life by the questionnaire.
* We will check the chest expansion by measuring tap.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients18 to 55 years of age (21)
* Both gender(M/F)
* Diagnosed as ILD ( sarcoidosis,acute interstitial pneumonia etc.)on clinical, radiological, and histopathological basis
* All included patients were clinically stable without exacerbations in the past 1 month.

Exclusion Criteria

* Patients with other significant respiratory disorders such as acute infections, pulmonary tuberculosis, COPD, asthma, bronchiectasis, lung carcinoma, and pneumothorax
* connective tissue disease-associated ILD
* Patients having other co morbid diseases preventing from exercise training, for example, disability due to orthopedic, neurological, and acute cardiac causes
* Physically and mentally unwell to attend the hospital for training
* Already completed or participated in a PR program in the past 1 year
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

sumera abdul hameed, Ms

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ittefaq Hospital

Lahore, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

imran amjad, phd

Role: CONTACT

03324390125

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

sumera abdul hameed, MS

Role: primary

03104548492

References

Explore related publications, articles, or registry entries linked to this study.

Bilyy A, El-Nakhal T, Kadlec J, Bartosik W, Tornout FV, Kouritas V. Preoperative training education with incentive spirometry may reduce postoperative pulmonary complications. Asian Cardiovasc Thorac Ann. 2020 Nov;28(9):592-597. doi: 10.1177/0218492320957158. Epub 2020 Sep 11.

Reference Type BACKGROUND
PMID: 32915659 (View on PubMed)

Larson M, Kim MJ. Respiratory muscle training with the incentive spirometer resistive breathing device. Heart Lung. 1984 Jul;13(4):341-5.

Reference Type BACKGROUND
PMID: 6564101 (View on PubMed)

Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med. 2000 Nov;162(5):1709-14. doi: 10.1164/ajrccm.162.5.9912026.

Reference Type BACKGROUND
PMID: 11069801 (View on PubMed)

Ho SC, Chiang LL, Cheng HF, Lin HC, Sheng DF, Kuo HP, Lin HC. The effect of incentive spirometry on chest expansion and breathing work in patients with chronic obstructive airway diseases: comparison of two methods. Chang Gung Med J. 2000 Feb;23(2):73-9.

Reference Type BACKGROUND
PMID: 10835801 (View on PubMed)

Rondinel TZ, Correa IF, Hoscheidt LM, Bueno MH, Da Silva LM, Reppold CT, Dal Lago P. Incentive spirometry combined with expiratory positive airway pressure improves asthma control and quality of life in asthma: a randomised controlled trial. J Asthma. 2015 Mar;52(2):220-6. doi: 10.3109/02770903.2014.956890. Epub 2014 Sep 2.

Reference Type BACKGROUND
PMID: 25144550 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR & AHS/23/0349

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.